Search This Blog

Wednesday, January 2, 2019

Abbott downgraded to Sell from Neutral at Citi


Citi analyst Amit Hazan downgraded Abbott Laboratories to Sell and lowered his price target for the shares to $68 from $72.

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.